Please assess the completion status of the following clinical trial:

Trial Title: Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Documented acute hepatitis C infection with detectable HCV-RNA (PCR-assay) and elevated serum alanine transferase (ALT) levels. An acute infection is defined by fulfilling two of the following 3 criteria within the preceding four months:~  1. known or suspected exposure to HCV,~ 2. documented seroconversion to positivity for antibodies against HCV,~ 3. a serum alanine transferase (ALT) level of more than 350 U/l with a documented normal level during the year before infection.~* Documented HIV-infection~* CD4 cells \> 300 /µl~* Ability to understand and sign a written consent form~* Women of child-bearing age: negative pregnancy test~Exclusion Criteria:~* Autoimmune hepatitis or other autoimmune disease~* Decompensated liver disease~* Decompensated renal disease, i.e. creatinine clearance \< 50 ml/min, according to Cockcroft-Gault~* Acute or chronic hepatitis B infection~* Acute infection with hepatitis A or other hepatotropic viruses~* New AIDS defining event less than 1 month prior to enrolment~* Malignancy other than cutaneous kaposi sarcoma treated with systemic chemo-therapy~* History of severe psychiatric conditions, in particular severe depression~* History of seizures~* History of organ transplantation~* Thyroid disease not medically compensable~* Severe heart disease~* Severe retinopathy~* Known allergy to the study drug or one of the galenic compounds~* Hypersensitivity to interferon a~* Thrombocytes \< 90 G/l, neutrophils \< 1.5 G/l, hemoglobin must not be \< 12g/dl (female) or \< 13 g/dl (male)~* Treatment with corticosteroids less than 3 months prior to enrolment~* Alcohol abuse or use of other recreational drugs~* Older than 65 years of age, younger than 18 years of age~* Pregnancy, breast-feeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).